ATI RN
Cardiovascular System Exam Questions
1. Which condition is caused by a bacterium that primarily affects the lungs but can spread to other parts of the body?
- A. Tuberculosis
- B. Pneumonia
- C. Legionnaires' disease
- D. Histoplasmosis
Correct answer: A
Rationale: The correct answer is A, Tuberculosis. Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs but can spread to other organs. Choice B, Pneumonia, is an infection that inflames the air sacs in one or both lungs. Choice C, Legionnaires' disease, is a severe form of pneumonia caused by the Legionella bacteria. Choice D, Histoplasmosis, is a fungal infection caused by inhaling spores of the Histoplasma capsulatum fungus.
2. Which condition is characterized by the sudden onset of shortness of breath, often occurring at night and associated with heart failure?
- A. Paroxysmal nocturnal dyspnea
- B. Sleep apnea
- C. Orthopnea
- D. Dyspnea
Correct answer: A
Rationale: Paroxysmal nocturnal dyspnea is the correct answer. It is characterized by the sudden onset of shortness of breath during sleep, often associated with heart failure. Choice B, Sleep apnea, involves pauses in breathing during sleep but is not specifically associated with heart failure. Choice C, Orthopnea, is difficulty breathing that occurs when lying down and is relieved by sitting up, not necessarily associated with heart failure. Choice D, Dyspnea, is a general term for difficulty breathing and does not specifically describe the sudden onset at night associated with heart failure as seen in paroxysmal nocturnal dyspnea.
3. Which medication is used to prevent blood clots by thinning the blood, reducing the risk of stroke and heart attack?
- A. Anticoagulant
- B. ACE inhibitor
- C. Beta-blocker
- D. Calcium channel blocker
Correct answer: A
Rationale: The correct answer is 'Anticoagulant.' Anticoagulants are medications specifically designed to prevent blood clots by thinning the blood, which effectively reduces the risk of stroke, heart attack, and other cardiovascular events. Choices B, C, and D, which are ACE inhibitors, beta-blockers, and calcium channel blockers, respectively, do not have the primary mechanism of action to prevent blood clot formation. ACE inhibitors, beta-blockers, and calcium channel blockers are commonly used for managing hypertension and other cardiovascular conditions by different mechanisms of action.
4. The client is given an alpha agonist. What might it be used for?
- A. For hemostasis
- B. To dilate the arteries
- C. To dilate the veins
- D. To decrease afterload
Correct answer: A
Rationale: Alpha agonists are used for hemostasis to help control bleeding by constricting blood vessels, leading to decreased blood flow to the area. Choices B, C, and D are incorrect as alpha agonists do not typically dilate arteries, dilate veins, or decrease afterload.
5. Which of the following is a chronic respiratory disease characterized by the irreversible obstruction of airflow?
- A. Chronic obstructive pulmonary disease (COPD)
- B. Asthma
- C. Pulmonary edema
- D. Bronchiectasis
Correct answer: A
Rationale: The correct answer is A, Chronic obstructive pulmonary disease (COPD). COPD is a chronic respiratory disease where the airflow in the lungs becomes obstructed, making it difficult to breathe. Choice B, Asthma, is a different chronic respiratory condition characterized by reversible airflow obstruction and airway hyperresponsiveness. Choice C, Pulmonary edema, is a condition where fluid accumulates in the lungs, leading to difficulty in breathing but not irreversible airflow obstruction. Choice D, Bronchiectasis, is a condition characterized by abnormal widening of the bronchial tubes, leading to recurrent respiratory infections, but it is not specifically defined by irreversible airflow obstruction.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access